Psychiatry & Neurology, Child & Adolescent Psychiatry · Brentwood, NY
NPI
1467551002
Since 2006
Specialty
Psychiatry & Neurology, Child & Adolescent Psychiatry
Code 2084P0804X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1841 Brentwood Rd
Brentwood, NY, 11717
Phone (631) 853-7300
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$640K
5,221 prescriptions
Company payments, 2025
$776
From 7 companies
Medicare prescription drug claims, 2024
In 2024, the drug Paris A Arianas prescribed most often to Medicare patients was Sertraline Hcl, with 511 prescriptions and refills. In total Paris A Arianas wrote 5,221 Medicare prescriptions that cost $640K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Sertraline Hcl Generic | 511 | 513 | 39 | $4,163 |
| Risperidone Generic | 397 | 397 | 34 | $4,578 |
| Aripiprazole Generic | 346 | 346 | 34 | $16K |
| Fluoxetine Hcl Generic | 289 | 289 | 24 | $2,222 |
| Olanzapine Generic | 278 | 278 | 21 | $6,209 |
| Quetiapine Fumarate Generic | 252 | 253 | 20 | $7,014 |
| Divalproex Sodium Generic | 240 | 242 | 18 | $6,670 |
| Lorazepam Generic | 208 | 208 | 22 | $1,867 |
| Clonazepam Generic | 199 | 199 | 31 | $1,471 |
| Citalopram Hbr Citalopram Hydrobromide | 191 | 191 | 15 | $1,340 |
| Escitalopram Oxalate Generic | 187 | 187 | 15 | $1,447 |
| Benztropine Mesylate Generic | 154 | 154 | 14 | $1,616 |
| Fluvoxamine Maleate Generic | 152 | 152 | Under 11 | $7,553 |
| Divalproex Sodium Er Divalproex Sodium | 105 | 113 | Under 11 | $7,082 |
| Ziprasidone Hcl Generic | 97 | 97 | Under 11 | $7,318 |
Brand drugs: 319 claims; generic drugs: 4,902 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paris A Arianas $776 ($776 in general payments such as food, travel and fees) from 7 companies. The largest payer was Neurocrine BioSciences, Inc. with $451.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 11 | $451 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $86.65 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $64.04 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $63.85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $53.87 |
| Axsome Therapeutics, Inc. AXSM | 1 | $30.03 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $26.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.